Karim Galzahr

Director
Mr. Galzahr, Managing Partner at OKG Capital, is a seasoned finance leader with 30+ years of expertise in M&A, asset management, and strategic advisory across tech and medtech.
See full team
Karim Galzahr
Background

Karim Galzahr is the Managing Partner at OKG Capital, a medtech and life sciences investment firm. With over 30 years of experience in finance, he specializes in M&A, asset management, corporate development, and strategic advisory across the technology and medical technology sectors.

Throughout his career, Galzahr has played a pivotal role in driving growth, securing high-value investments, and advising industry leaders on financial strategy and business expansion. His expertise spans the intersection of finance, technology, and healthcare innovation, positioning him as a key player in advancing medtech solutions.

Our Pipeline

The Future of Cancer Treatment

OS Therapies is not just addressing Osteosarcoma. With the other uses of our HER2 target cancer immunotherapy and the addition of our OST-tADC tunable Antibody Drug Conjugate silicone linker platform, we are paving the way for the next-generation of cancer treatments.
Female chemist working on osteosarcoma treatments | OS TherapiesLab technician working on cancer treatments | OS TherapiesFemale chemist working on cancer treatments